Acrivon Therapeutics, Inc.
ACRV
$1.62
$0.095.88%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -80.56M | -76.98M | -69.00M | -64.12M | -60.39M |
| Total Depreciation and Amortization | 1.01M | 852.00K | 734.00K | 635.00K | 536.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.44M | 10.96M | 10.94M | 10.36M | 9.07M |
| Change in Net Operating Assets | 2.44M | 4.49M | 4.17M | 4.76M | 8.14M |
| Cash from Operations | -65.67M | -60.68M | -53.16M | -48.37M | -42.64M |
| Capital Expenditure | -2.77M | -3.09M | -2.10M | -2.08M | -1.29M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.00M | -42.56M | -58.04M | 49.32M | 52.01M |
| Cash from Investing | -51.77M | -45.65M | -60.14M | 47.24M | 50.72M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 70.09M | 70.41M | 70.48M | 854.00K | 775.00K |
| Repurchase of Common Stock | -2.52M | -3.17M | -1.97M | -1.46M | -1.30M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 53.46M | 52.43M | 52.74M | -1.12M | -1.03M |
| Cash from Financing | 121.03M | 119.66M | 121.25M | -1.73M | -1.55M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.59M | 13.34M | 7.95M | -2.85M | 6.52M |
